Study Details
A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients with Stargardt’s Macular Dystrophy (SMD)
Clinicaltrials.gov ID
Astellas Study ID
7316-CL-0006
EudraCT ID
2012-002827-14
Condition
Eye Disorder with Progressive Visual Loss
Phase
N/A
Age
18 years - N/A
Sex
Female & Male
Product
N/A
Type
Observational
Trial Dates
Jan 2013 - Oct 2019
Masking
Not Available
Enrollment number
12
Follow-up to 5 Years of a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients with Stargardt’s Macular Dystrophy (SMD)
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients with Stargardt’s Macular Dystrophy (SMD)? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Newcastle on Tyne NHS Foundation Trust
Newcastle upon Tyne, United Kingdom, NE7 7DN
Moorefields Eye Hospital NHS Foundation Trust
London, United Kingdom, EC1V2PD